CryoLogyx
![]() |
|||||||||||||||||||||||||||||||||||||||||||||||||||
CryoLogyx. Founded by Dr. Tom Congdon and Prof. Matt Gibson, CryoLogyx specializes in developing high-quality cryopreservation solutions for cell-based assays in drug discovery. Here are some key points about CryoLogyx:
Discover CryoLogyx’s advanced cryopreservation solutions – simply thaw with cell culture medium, and the cells are ready for use within 24 hours post-thaw. If you have any more questions or need further information, feel free to contact us.
Learn more:
Watch the videos :
website: www.cryologyx.com |
![Liver cancers](https://www.clinisciences.com/en/upload/23-wcnpbn.png)
Liver cancers
Liver cancer or hepatic cancer is a cancer that originates in the liver. Liver cancers are malignant tumours that develop on the surface or inside the liver. Liver tumours are discovered on medical imaging equipment (often by accident) or present symptomatically in the form of an abdominal mass, abdominal pain, jaundice, nausea or liver dysfunction.
Liver cancer is a complex and formidable disease, and can present in a variety of forms, each with its own specific characteristics. The liver, a vital organ, plays an essential role in metabolism, digestion and detoxification. The development of liver cancer often results from the accumulation of genetic mutations in liver cells, leading to uncontrolled cell growth.
Risk factors include viral hepatitis, cirrhosis and other liver diseases. Research into liver cells and cell lines specific to liver cancer offers crucial insights into the underlying molecular mechanisms and the development of targeted therapeutic approaches.
Advances in cell and molecular biology have made it possible to identify various types of liver cells involved in liver cancer, paving the way for in-depth studies into the mechanisms of tumour progression.
Select the cells below to find the most commonly used cell lines for each of the specified cell types.
Search result : 1 product found
Refine your search :
- Cell line 1